These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 15950811
1. Implications of P16/CDKN2A deletion in pleural mesotheliomas. Ladanyi M. Lung Cancer; 2005 Jul; 49 Suppl 1():S95-8. PubMed ID: 15950811 [Abstract] [Full Text] [Related]
2. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Clin Cancer Res; 2003 Jun; 9(6):2108-13. PubMed ID: 12796375 [Abstract] [Full Text] [Related]
4. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Illei PB, Ladanyi M, Rusch VW, Zakowski MF. Cancer; 2003 Feb 25; 99(1):51-6. PubMed ID: 12589646 [Abstract] [Full Text] [Related]
6. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. Matsumoto S, Nabeshima K, Kamei T, Hiroshima K, Kawahara K, Hata S, Marukawa K, Matsuno Y, Taguchi K, Tsujimura T. Cancer Cytopathol; 2013 Aug 25; 121(8):415-22. PubMed ID: 23450849 [Abstract] [Full Text] [Related]
9. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS. Arch Otolaryngol Head Neck Surg; 2006 Apr 25; 132(4):409-15. PubMed ID: 16618910 [Abstract] [Full Text] [Related]
11. CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival. Krasinskas AM, Bartlett DL, Cieply K, Dacic S. Mod Pathol; 2010 Apr 25; 23(4):531-8. PubMed ID: 20081810 [Abstract] [Full Text] [Related]
12. Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma. Wu D, Hiroshima K, Yusa T, Ozaki D, Koh E, Sekine Y, Matsumoto S, Nabeshima K, Sato A, Tsujimura T, Yamakawa H, Tada Y, Shimada H, Tagawa M. Ann Diagn Pathol; 2017 Feb 25; 26():31-37. PubMed ID: 28038708 [Abstract] [Full Text] [Related]
13. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy. Chen ZH, Zhang H, Savarese TM. Cancer Res; 1996 Mar 01; 56(5):1083-90. PubMed ID: 8640765 [Abstract] [Full Text] [Related]
15. Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma. Chapel DB, Dubuc AM, Hornick JL, Sholl LM. Histopathology; 2021 Jun 01; 78(7):1032-1042. PubMed ID: 33387364 [Abstract] [Full Text] [Related]
16. p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma. Hwang H, Tse C, Rodriguez S, Gown A, Churg A. Am J Surg Pathol; 2014 May 01; 38(5):681-8. PubMed ID: 24503757 [Abstract] [Full Text] [Related]